Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Price : 2.325 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 2.19 | 2.31 | 2.19 | 2.30 | 3.195M |
| Aug 20, 2026 | 2.40 | 2.40 | 2.17 | 2.18 | 4.746M |
| Aug 19, 2026 | 2.46 | 2.475 | 2.39 | 2.41 | 1.776M |
| Aug 18, 2026 | 2.33 | 2.44 | 2.325 | 2.42 | 2.905M |
| Aug 17, 2026 | 2.31 | 2.39 | 2.290 | 2.34 | 3.530M |
| Aug 14, 2026 | 2.32 | 2.335 | 2.265 | 2.32 | 1.763M |
| Aug 13, 2026 | 2.37 | 2.39 | 2.32 | 2.34 | 2.315M |
| Aug 12, 2026 | 2.41 | 2.455 | 2.35 | 2.35 | 2.569M |
| Aug 11, 2026 | 2.42 | 2.45 | 2.31 | 2.43 | 3.032M |
| Aug 10, 2026 | 2.45 | 2.49 | 2.38 | 2.40 | 2.697M |
| Aug 07, 2026 | 2.435 | 2.475 | 2.29 | 2.47 | 3.086M |
| Aug 06, 2026 | 1.96 | 2.44 | 1.96 | 2.36 | 4.891M |
| Aug 05, 2026 | 2.515 | 2.515 | 2.40 | 2.45 | 3.974M |
| Aug 04, 2026 | 2.33 | 2.52 | 2.32 | 2.49 | 3.909M |
| Aug 03, 2026 | 2.29 | 2.34 | 2.22 | 2.33 | 2.053M |
| Jul 31, 2026 | 2.32 | 2.35 | 2.245 | 2.31 | 2.768M |
| Jul 30, 2026 | 2.32 | 2.40 | 2.285 | 2.34 | 2.464M |
| Jul 29, 2026 | 2.38 | 2.415 | 2.29 | 2.32 | 2.476M |
| Jul 28, 2026 | 2.24 | 2.345 | 2.165 | 2.34 | 2.680M |
| Jul 27, 2026 | 2.30 | 2.375 | 2.16 | 2.23 | 2.957M |
| Jul 24, 2026 | 2.30 | 2.345 | 2.24 | 2.29 | 1.682M |
| Jul 23, 2026 | 2.21 | 2.345 | 2.190 | 2.30 | 2.708M |
| Jul 22, 2026 | 2.36 | 2.37 | 2.19 | 2.25 | 3.602M |
| Jul 21, 2026 | 2.33 | 2.40 | 2.26 | 2.38 | 2.349M |
| Jul 20, 2026 | 2.405 | 2.42 | 2.26 | 2.33 | 3.096M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Viatris, Inc. | 16.54 |
| Pfizer Inc. | 27.98 |
| ANI Pharmaceuticals, Inc. | 74.24 |
| Corcept Therapeutics, Inc. | 123.20 |
| Veru, Inc. | 2.61 |
Price Related Metrics
| PS Ratio | 21.93 |
| Price to Book Value | 5.927 |
| Earnings Yield | -6.58% |
| Market Cap | 1.034B |